 |
PDBsum entry 1iar
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Cytokine/receptor
|
PDB id
|
|
|
|
1iar
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Crystal structure of the interleukin-4/receptor alpha chain complex reveals a mosaic binding interface.
|
 |
|
Authors
|
 |
T.Hage,
W.Sebald,
P.Reinemer.
|
 |
|
Ref.
|
 |
Cell, 1999,
97,
271-281.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Interleukin-4 (IL-4) is a principal regulatory cytokine during an immune
response and a crucial determinant for allergy and asthma. IL-4 binds with high
affinity and specificity to the ectodomain of the IL-4 receptor alpha chain
(IL4-BP). Subsequently, this intermediate complex recruits the common gamma
chain (gamma c), thereby initiating transmembrane signaling. The crystal
structure of the intermediate complex between human IL-4 and IL4-BP was
determined at 2.3 A resolution. It reveals a novel spatial orientation of the
two proteins, a small but unexpected conformational change in the receptor-bound
IL-4, and an interface with three separate clusters of trans-interacting
residues. Novel insights on ligand binding in the cytokine receptor family and a
paradigm for receptors of IL-2, IL-7, IL-9, and IL-15, which all utilize gamma
c, are provided.
|
 |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. Structure of Receptor-Bound IL-4Ribbon
representation illustrating conformational differences between
free IL-4 (yellow, 1rcb [[55]; green, 1int [ [52]) and IL-4 in
complex with IL4-BP (red, wild-type IL-4; blue, SeMet-IL-4).
|
 |
Figure 4.
|
 |
|
 |
 |
|
The above figures are
reprinted
by permission from Cell Press:
Cell
(1999,
97,
271-281)
copyright 1999.
|
 |
|
Secondary reference #1
|
 |
|
Title
|
 |
Crystals of a 1:1 complex between human interleukin-4 and the extracellular domain of its receptor alpha chain.
|
 |
|
Authors
|
 |
T.Hage,
P.Reinemer,
W.Sebald.
|
 |
|
Ref.
|
 |
Eur J Biochem, 1998,
258,
831-836.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
|
 |
 |
 |
|
 |
|
 |
Figure 2.
Fig. 2. Separation of excess free IL4 from the preformed complex with IL4BP and SDSPAGE analysis of chromatographed fractions. (A)
Preparative gel filtration chromatography of IL4 and IL4 :IL4BP complex. The IL4 (600
µM)
and IL4BP (500
µM)
were mixed in a
1.2
:1
stoichiometry and equilibrated for 30 min at 4°C. The sample (400 µl) was applied to a Sephacryl S200 column (Pharmacia) and eluted with the
same buffer at
10
ml/h. The elution profile of IL4 is shown as a control, indicating that excess free ligand upon complex formation can be removed.
(B) Coomassiestained gel (12%) run under nonreducing conditions.
|
 |
Figure 5.
Fig. 5. Binding of SeIL4tetraMet to IL4BP.
Association and dissoci
ation of the selenomethioninelabelled IL4 variant was measured by the
BIAcore technique using biosensor immobilised IL4BP. Binding of IL4
is shown as a control.
|
 |
|
 |
 |
|
The above figures are
reproduced from the cited reference
with permission from the Federation of European Biochemical Societies
|
 |
|
|
|
|
 |